Answers are grounded in this paper and cite their sources.
Background Currently, the number of adjuvants authorized for allergen-specific immunotherapy (AIT) is limited, and their immune-metabolic effects are largely unknown. To identify promising adjuvants for AIT, we systematically compared representative examples of all commercially available adjuvants used in vaccines and AIT products that are authorized for human use. Methods Mouse myeloid dendritic cells (mDCs) were stimulated with different vaccines and AIT products and analyzed for their activation status (cytokine secretion and CD69 and MHCII expression), metabolic state (metabolic flux analyses, Warburg metabolism, and glucose consumption), and the underlying mechanisms (Western blot and inhibitor experiments). Results Vaccines and AIT products induced distinct immune-metabolic profiles, characterized by either: 1) no detectable mDC activation [lipid nanoparticle (LNP)-formulated vaccine]; 2) modest activation of glucose metabolism (GM) with prominent CCL2 secretion (alum-adjuvanted AIT product); 3) strongly increased GM and chemokine CCL2 secretion (MF59-adjuvanted vaccine); 4) activation of GM with pre-dominantly pro-inflammatory cytokines [monophosphoryl lipid A (MPL)- and aluminum/QS-21-adjuvanted vaccines]; 5) transient metabolic activation with pro- and anti-inflammatory cytokines (MPL- and l -tyrosine-adjuvanted AIT product); or 6) activation of GM paralleled by anti-inflammatory IL-10 secretion (CpG1018-adjuvanted vaccine). The effects were at least in part adjuvant-mediated and independent of either antigen or buffer. Mechanistically, the vaccines were shown to trigger nuclear factor kappa B (NFκB), mitogen-activated protein (MAP) kinase, and mammalian target of rapamycin (mTOR) signaling. The activation of mTOR was shown to contribute to the observed immune-metabolic effects. Conclusion Our study provides a comparative analysis of the immune-metabolic effects of all currently available adjuvants authorized for human use in Germany in mouse mDCs, improving our mechanistic understanding and paving the way for further studies that may enable their safe and efficient application also beyond the current scope of use.
No takes yet. Share an insight, caveat, or question.
Schiller et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: